Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy

被引:24
|
作者
Furuichi, Kengo [1 ]
Shimizu, Miho [1 ]
Yuzawa, Yukio [2 ]
Hara, Akinori [1 ]
Toyama, Tadashi [1 ]
Kitamura, Hiroshi [3 ]
Suzuki, Yoshiki [4 ]
Sato, Hiroshi [5 ]
Uesugi, Noriko [6 ]
Ubara, Yoshifumi [7 ]
Hohino, Junichi [7 ]
Hisano, Satoshi [8 ]
Ueda, Yoshihiko [9 ]
Nishi, Shinichi [10 ,11 ]
Yokoyama, Hitoshi [12 ]
Nishino, Tomoya [13 ]
Kohagura, Kentaro [14 ]
Ogawa, Daisuke [15 ]
Mise, Koki [15 ]
Shibagaki, Yugo [16 ]
Makino, Hirofumi [15 ]
Matsuo, Seiichi [17 ]
Wada, Takashi [18 ]
机构
[1] Kanazawa Univ Hosp, Dept Nephrol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan
[2] Fujita Hlth Univ Hosp, Dept Nephrol, 1-98 Dengakugakubo Kutsukake Cho, Toyoake, Aichi 4701192, Japan
[3] Natl Hosp Org, Chiba East Natl Hosp, Clin Res Ctr, Dept Pathol, 673 Nitona, Chiba, Chiba 2608712, Japan
[4] Niigata Univ, Hlth Adm Ctr, Nishi Ku, 2-8085 Igarashi, Niigata, Niigata 9502181, Japan
[5] Tohoku Univ, Grad Sch Pharmaceut Sci, Clin Pharmacol & Therapeut, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan
[6] Univ Tsukuba, Fac Med, Dept Pathol, Tsukuba, Ibaraki, Japan
[7] Toranomon Gen Hosp, Nephrol Ctr, 2-2-2 Toranomon, Tokyo 1058470, Japan
[8] Fukuoka Univ, Fac Med, Dept Pathol, Fukuoka, Fukuoka, Japan
[9] Dokkyo Med Univ, Koshigaya Hosp, Dept Pathol, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 3438555, Japan
[10] Kobe Univ, Grad Sch Med, Div Nephrol, 7-5-1 Kusunoki, Kobe, Hyogo 6500017, Japan
[11] Kobe Univ, Grad Sch Med, Kidney Ctr, 7-5-1 Kusunoki, Kobe, Hyogo 6500017, Japan
[12] Kanazawa Med Univ, Sch Med, Dept Nephrol, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan
[13] Nagasaki Univ, Sch Med, Dept Internal Med 2, 1-7-1 Sakamoto, Nagasaki 8528501, Japan
[14] Univ Ryukyus, Sch Med, Dept Cardiovasc Med Nephrol & Neurol, 207 Uehara,Nishihara Cho, Okinawa 9030215, Japan
[15] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan
[16] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens,Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan
[17] Nagoya Univ, Grad Sch Med, Dept Internal Med, Div Nephrol,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan
[18] Kanazawa Univ, Dept Nephrol & Lab Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan
关键词
Japanese classification of diabetic nephropathy; Kidney biopsy; Nodular lesions; Mesangiolysis; Exudative lesions; Widening of the subendothelial space; JOINT COMMITTEE; KIDNEY-DISEASE; LESIONS; GLOMERULOSCLEROSIS; PREDICTORS; MELLITUS; OUTCOMES; DECLINE; IMPACT;
D O I
10.1007/s10157-017-1485-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The Japanese classification of diabetic nephropathy reflects the risks of mortality, cardiovascular events and kidney prognosis and is clinically useful. Furthermore, pathological findings of diabetic nephropathy are useful for predicting prognoses. In this study, we evaluated the characteristics of pathological findings in relation to the Japanese classification of diabetic nephropathy and their ability to predict prognosis. The clinical data of 600 biopsy-confirmed diabetic nephropathy patients were collected retrospectively from 13 centers across Japan. Composite kidney events, kidney death, cardiovascular events, all-cause mortality, and decreasing rate of estimated GFR (eGFR) were evaluated based on the Japanese classification of diabetic nephropathy. The median observation period was 70.4 (IQR 20.9-101.0) months. Each stage had specific characteristic pathological findings. Diffuse lesions, interstitial fibrosis and/or tubular atrophy (IFTA), interstitial cell infiltration, arteriolar hyalinosis, and intimal thickening were detected in more than half the cases, even in Stage 1. An analysis of the impacts on outcomes in all data showed that hazard ratios of diffuse lesions, widening of the subendothelial space, exudative lesions, mesangiolysis, IFTA, and interstitial cell infiltration were 2.7, 2.8, 2.7, 2.6, 3.5, and 3.7, respectively. Median declining speed of eGFR in all cases was 5.61 mL/min/1.73 m(2)/year, and the median rate of declining kidney function within 2 years after kidney biopsy was 24.0%. This study indicated that pathological findings could categorize the high-risk group as well as the Japanese classification of diabetic nephropathy. Further study using biopsy specimens is required to clarify the pathogenesis of diabetic kidney disease.
引用
收藏
页码:570 / 582
页数:13
相关论文
共 50 条
  • [1] Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy
    Kengo Furuichi
    Miho Shimizu
    Yukio Yuzawa
    Akinori Hara
    Tadashi Toyama
    Hiroshi Kitamura
    Yoshiki Suzuki
    Hiroshi Sato
    Noriko Uesugi
    Yoshifumi Ubara
    Junichi Hohino
    Satoshi Hisano
    Yoshihiko Ueda
    Shinichi Nishi
    Hitoshi Yokoyama
    Tomoya Nishino
    Kentaro Kohagura
    Daisuke Ogawa
    Koki Mise
    Yugo Shibagaki
    Hirofumi Makino
    Seiichi Matsuo
    Takashi Wada
    [J]. Clinical and Experimental Nephrology, 2018, 22 : 570 - 582
  • [2] Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy
    Li Zhuo
    Nianrong Zhang
    Guming Zou
    Dapeng Chen
    Wenge Li
    [J]. Frontiers of Medicine, 2017, 11 : 386 - 392
  • [3] Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy
    Zhuo, Li
    Zhang, Nianrong
    Zou, Guming
    Chen, Dapeng
    Li, Wenge
    [J]. FRONTIERS OF MEDICINE, 2017, 11 (03) : 386 - 392
  • [4] Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy
    Shimizu, Miho
    Furuichi, Kengo
    Toyama, Tadashi
    Kitajima, Shinji
    Hara, Akinori
    Kitagawa, Kiyoki
    Iwata, Yasunori
    Sakai, Norihiko
    Takamura, Toshinari
    Yoshimura, Mitsuhiro
    Yokoyama, Hitoshi
    Kaneko, Shuichi
    Wada, Takashi
    [J]. DIABETES CARE, 2013, 36 (11) : 3655 - 3662
  • [5] DECREASING SPEED OF KINDEY FUNCTION IN PATIENTS WITH BIOPSY-PROVEN DIABETIC NEPHROPATHY
    Furuichi, Kengo
    Yuzawa, Yukio
    Ubara, Yoshifumi
    Shimizu, Miho
    Toyama, Tadashi
    Iwata, Yasunori
    Sakai, Norihiko
    Wada, Takashi
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [6] Poor Renal and Cardiovascular Outcomes in Patients with Biopsy-Proven Diabetic Nephropathy
    Wang, Yiyun
    Zhou, Ting
    Zhang, Qiming
    Fei, Yang
    Li, Ze
    Li, Shiqi
    He, Li
    Zhang, Qunzi
    Dong, Yang
    Fan, Ying
    Wang, Niansong
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2020, 45 (03): : 378 - 390
  • [7] Urinary Exosomal MicroRNA Signatures in Nephrotic, Biopsy-Proven Diabetic Nephropathy
    Lee, Wen-Chin
    Li, Lung-Chih
    Ng, Hwee-Yeong
    Lin, Pei-Ting
    Chiou, Terry Ting-Yu
    Kuo, Wei-Hung
    Lee, Chien-Te
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [8] Impact of tubulointerstitial lesions on anaemia in patients with biopsy-proven diabetic nephropathy
    Mise, K.
    Hoshino, J.
    Ueno, T.
    Imafuku, A.
    Kawada, M.
    Sumida, K.
    Hiramatsu, R.
    Hasegawa, E.
    Yamanouchi, M.
    Hayami, N.
    Suwabe, T.
    Sawa, N.
    Fujii, T.
    Hara, S.
    Ohashi, K.
    Takaichi, K.
    Ubara, Y.
    [J]. DIABETIC MEDICINE, 2015, 32 (04) : 546 - 555
  • [9] Clinical and Histological Predictors of Renal Survival in Patients with Biopsy-Proven Diabetic Nephropathy
    Zhou, Ting
    Wang, Yiyun
    Shen, Li
    Li, Ze
    Jia, Junjie
    Wang, Niansong
    Fan, Ying
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 273 - 273
  • [10] Clinicopathologic features and prognostic factors in older patients with biopsy-proven diabetic nephropathy
    Lijun Zhao
    Honghong Ren
    Rui Zhang
    Tingli Wang
    Yutong Zou
    Huan Xu
    Lin Li
    Mark E. Cooper
    Fang Liu
    [J]. International Urology and Nephrology, 2021, 53 : 1161 - 1170